Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Gleevec

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Onco360 Named National Specialty Pharmacy for Imatinib Solution
    Onco360 Named National Specialty Pharmacy for Imatinib Solution

    02 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/02/3305615/0/en/onco360-has-been-selected-as-a-national-specialty-pharmacy-provider-for-imkeldi-imatinib-oral-solution.html

    GLOBENEWSWIRE
    02 Jun 2026
    Share Share
    At ASCO 2026, A 'Paradigm Shift' For A Rare Gut Cancer Looms
    At ASCO 2026, A 'Paradigm Shift' For A Rare Gut Cancer Looms

    01 Jun 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/asco-2026-paradigm-shift-rare-gut-cancer-looms

    FIERCE BIOTECH
    01 Jun 2026
    Share Share
    Inhibikase Starts Enrollment in Global Phase 3 IMPROVE-PAH Trial
    Inhibikase Starts Enrollment in Global Phase 3 IMPROVE-PAH Trial

    07 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/07/3269056/0/en/Inhibikase-Therapeutics-Announces-Enrollment-of-First-Patient-in-IMPROVE-PAH-Global-Phase-3-Study-of-IKT-001-in-the-Treatment-of-Pulmonary-Arterial-Hypertension.html

    GLOBENEWSWIRE
    07 Apr 2026
    Share Share
    Shorla Expands U.S. Presence With Sales, Market Access Teams
    Shorla Expands U.S. Presence With Sales, Market Access Teams

    04 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250304027981/en

    BUSINESSWIRE
    04 Mar 2025
    Share Share
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
    Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI

    28 Nov 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/shilpa-medicares-jv-oncosol-gets-usfda-approval-for-imkeldi-16490

    INDPHARMAPOST
    28 Nov 2024
    Share Share
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec
    Shorla gains FDA nod for 1st oral version of Novartis' Gleevec

    27 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241125044117/en/Shorla-Oncology-Announces-FDA-Approval-of-IMKELDI-imatinib-Oral-Solution-an-Oral-Liquid-for-the-Treatment-of-Certain-Forms-of-Leukemia-and-Other-Cancers

    BUSINESSWIRE
    27 Nov 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.